ABOS earnings
Acumen Pharmaceuticals (ABOS) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
- ABOS beat EPS estimates in 9 of its last 16 reports.
ABOS earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q3 2026 | Oct 26, 2026 | -0.35 | -0.39 | 9.93% | – |
| Q2 2026 | Aug 12, 2026 | -0.45 | -0.36 | -25.23% | – |
| Q1 2026 | May 12, 2026 | -0.33 | -0.40 | 18.07% | – |
| Q4 2025 | Mar 26, 2026 | -0.41 | -0.50 | 18.00% | – |
| Q3 2025 | Nov 12, 2025 | -0.44 | -0.63 | 30.16% | – |
| Q2 2025 | Aug 12, 2025 | -0.68 | -0.54 | -25.93% | – |
| Q1 2025 | May 13, 2025 | -0.48 | -0.56 | 14.29% | – |
| Q4 2024 | Mar 27, 2025 | -0.62 | -0.47 | -31.91% | – |
| Q3 2024 | Nov 12, 2024 | -0.50 | -0.36 | -38.89% | – |
| Q2 2024 | Aug 13, 2024 | -0.34 | -0.28 | -21.43% | – |
| Q1 2024 | May 14, 2024 | -0.25 | -0.23 | -8.70% | – |
| Q4 2023 | Mar 26, 2024 | -0.29 | – | – | $290.00K |
| Q3 2023 | Nov 13, 2023 | -0.24 | -0.31 | 22.58% | – |
| Q2 2023 | Aug 8, 2023 | -0.28 | -0.36 | 22.22% | – |
| Q1 2023 | May 9, 2023 | -0.28 | -0.33 | 15.15% | – |
| Q4 2022 | Mar 27, 2023 | -0.32 | -0.28 | -14.29% | – |
| Q3 2022 | Nov 14, 2022 | -0.26 | -0.27 | 3.70% | – |